Indium 111-monoclonal antimyosin antibody and magnetic resonance imaging in the diagnosis of acute Lyme myopericarditis.

BACKGROUND Lyme borreliosis is a tick-borne multisystem disorder that may present as self-limiting early or persistent chronic diseases of the skin, nervous system, joints, heart, and other organs. Cardiac involvement has mainly been reported as acute atrioventricular conduction disturbances or transient ventricular dysfunction. METHODS AND RESULTS We treated a patient with clinical signs of acute myopericarditis and serologic evidence of Lyme borreliosis confirmed by silver staining of endomyocardial biopsy specimens and indium 111-monoclonal antimyosin antibody scan, which we believe has not been reported previously. Additionally, magnetic resonance imaging revealed epicardial and myocardial areas of increased intensity. CONCLUSION Indium 111-monoclonal antimyosin antibody scanning and magnetic resonance imaging might play an additional important role in assessing and confirming the diagnosis of Lyme carditis in the presence of clinical symptoms and positive serologic findings.

[1]  G. Stanek,et al.  Clinical outcome of Borrelia burgdorferi related dilated cardiomyopathy after antibiotic treatment , 1992, The Lancet.

[2]  I. Carrió,et al.  Early Postoperative Reduction ofMonoclonal Antimyosin Antibody Uptake Is Associated With Absent Rejection‐Related Complcations After Heart Transplantation , 1992, Circulation.

[3]  G. Stanek,et al.  Lyme borreliosis as a cause of myocarditis and heart muscle disease. , 1991, European heart journal.

[4]  S. Malawista,et al.  Lyme disease: recommendations for diagnosis and treatment. , 1991, Annals of Internal Medicine.

[5]  M. R. van der Linde,et al.  Lyme carditis: clinical characteristics of 105 cases. , 1991, Scandinavian journal of infectious diseases. Supplementum.

[6]  G. Stanek,et al.  Borrelia burgdorferi as an etiologic agent in chronic heart failure? , 1991, Scandinavian journal of infectious diseases. Supplementum.

[7]  I. Carrió,et al.  Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  I. Carrió,et al.  Indium-111-monoclonal antimyosin antibody studies after the first year of heart transplantation. Identification of risk groups for developing rejection during long-term follow-up and clinical implications. , 1990, Circulation.

[9]  H. Aretz.  The endomyocardial biopsy revisited. , 1990, Mayo Clinic proceedings.

[10]  G. Stanek,et al.  Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. , 1990, The New England journal of medicine.

[11]  H. Crijns,et al.  Transient complete AV block in Lyme disease. Electrophysiologic observations. , 1989, Chest.

[12]  H. Crijns,et al.  Demonstration of spirochetes in cardiac biopsies of patients with Lyme disease. , 1989, The Journal of infectious diseases.

[13]  I. Carrió,et al.  High prevalence of myocardial monoclonal antimyosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy. , 1989, Journal of the American College of Cardiology.

[14]  J. Mason,et al.  Clinical merit of endomyocardial biopsy. , 1989, Circulation.

[15]  A. Steere.  Medical progress. Lyme disease , 1989 .

[16]  I. Carrió,et al.  Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  I. Palacios,et al.  Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. , 1987, Circulation.

[18]  F. Prato,et al.  Diagnostic applicability of magnetic resonance imaging in assessing human cardiac allograft rejection. , 1987, The American journal of cardiology.

[19]  W. Edwards,et al.  Myocarditis. A histopathologic definition and classification. , 1987, The American journal of cardiovascular pathology.

[20]  F. Chandler,et al.  Lyme carditis. Electrophysiologic and histopathologic study. , 1986, The American journal of medicine.

[21]  I. Clements,et al.  Cardiac involvement in Lyme disease: manifestations and management. , 1986, Mayo Clinic proceedings.

[22]  F. Sheehan,et al.  Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. , 1986, Circulation.

[23]  C. Higgins,et al.  Overview of MR of the heart--1986. , 1986, AJR. American journal of roentgenology.

[24]  N. Fisher,et al.  Gallium-positive Lyme Disease Myocarditis , 1985, Clinical nuclear medicine.

[25]  P. Duray,et al.  Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium. , 1985, Annals of internal medicine.

[26]  G. Wisenberg,et al.  Detection of atrial myxoma by magnetic resonance imaging. , 1985, The American journal of cardiology.

[27]  I. Szer,et al.  Lyme myocarditis diagnosed by gallium scan. , 1984, The Journal of pediatrics.

[28]  R. Gunnar,et al.  Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. , 1984, Circulation.

[29]  J. P. Davis,et al.  Lyme disease: A tick-borne spirochetosis , 1983 .

[30]  J. Fallon,et al.  Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres. , 1982, Science.

[31]  E. Haber,et al.  Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid. , 1980, Science.

[32]  A. Steere,et al.  Lyme Carditis: Cardiac Abnormalities of Lyme Disease , 1980 .

[33]  G. Steiner.  Modified silver stain of microorganisms in tissues. , 1950, American journal of clinical pathology.